Appointed CEO of Novacyt in 2014
Over 30 years in healthcare; pharmaceuticals & medical device markets
Internationally experienced leader with multi-disciplinary background
Led multiple successful exits; Biocompatibles Eyecare, ClearLab, VisionTec, Optivue and Lab21.
C-level executive with FTSE 250 (Biocompatibles International) and NASDAQ (1-800 CONTACTS)